Intellia Therapeutics (NTLA) Q2 2026 Earnings

30AprConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-1.02
-0.96
-0.89
-0.83

Details

Expected EPS
-0.913816
Actual EPS
N/A
Surprise EPS
0.91
Surprise Percent
+100%

Description

Intellia Therapeutics (NTLA) will report earnings of for Q2 2026 on April 30, 2026.

0 Comments

Share your thoughts